The subdued activity has been continuing over the last few weeks and could be attributed to volatile market conditions since the outbreak of the coronavirus (COVID-19).
While the US witnessed a decline in deal volume by 21,5 percent, the UK and China witnessed deal volumes declining by 32 percent and 4,4 percent, respectively.
Sectors such as travel and tourism also witnessed a decline in deal activity, while the healthcare sector (including pharmaceuticals and medical equipment) and the retail sector witnessed an improvement in deal activity.
Most key deal types witnessed a decline in volume. Mergers and acquisitions deal volume declined by 36,4 percent, and the number of private equity, venture financing and partnerships deals dropped by 52,7 percent, 22,5 percent and 7,6 percent, respectively.